171 related articles for article (PubMed ID: 18234575)
1. FGF23 is elevated in Gambian children with rickets.
Prentice A; Ceesay M; Nigdikar S; Allen SJ; Pettifor JM
Bone; 2008 Apr; 42(4):788-97. PubMed ID: 18234575
[TBL] [Abstract][Full Text] [Related]
2. Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: possible aetiological factors.
Braithwaite V; Jarjou LM; Goldberg GR; Jones H; Pettifor JM; Prentice A
Bone; 2012 Jan; 50(1):218-25. PubMed ID: 22023931
[TBL] [Abstract][Full Text] [Related]
3. Intact fibroblast growth factor 23 and fragments in plasma from Gambian children.
Braithwaite V; Bruggraber SF; Prentice A
Osteoporos Int; 2013 Mar; 24(3):1121-4. PubMed ID: 22648001
[TBL] [Abstract][Full Text] [Related]
4. Iron status and fibroblast growth factor-23 in Gambian children.
Braithwaite V; Jarjou LM; Goldberg GR; Prentice A
Bone; 2012 Jun; 50(6):1351-6. PubMed ID: 22465847
[TBL] [Abstract][Full Text] [Related]
5. Aetiology of nutritional rickets in rural Bangladeshi children.
Ahmed S; Goldberg GR; Raqib R; Roy SK; Haque S; Braithwaite VS; Pettifor JM; Prentice A
Bone; 2020 Jul; 136():115357. PubMed ID: 32276153
[TBL] [Abstract][Full Text] [Related]
6. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children.
Braithwaite V; Jones KS; Assar S; Schoenmakers I; Prentice A
Endocr Connect; 2014; 3(1):1-10. PubMed ID: 24258305
[TBL] [Abstract][Full Text] [Related]
7. The aetiology of rickets-like lower limb deformities in Malawian children.
Braithwaite VS; Freeman R; Greenwood CL; Summers DM; Nigdikar S; Lavy CBD; Offiah AC; Bishop NJ; Cashman J; Prentice A
Osteoporos Int; 2016 Jul; 27(7):2367-2372. PubMed ID: 27059923
[TBL] [Abstract][Full Text] [Related]
8. Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.
Kubota T; Kitaoka T; Miura K; Fujiwara M; Ohata Y; Miyoshi Y; Yamamoto K; Takeyari S; Yamamoto T; Namba N; Ozono K
Horm Res Paediatr; 2014; 81(4):251-7. PubMed ID: 24577200
[TBL] [Abstract][Full Text] [Related]
9. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children.
Atapattu N; Shaw N; Högler W
Pediatr Res; 2013 Nov; 74(5):552-6. PubMed ID: 23999068
[TBL] [Abstract][Full Text] [Related]
11. The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism.
Braithwaite VS; Prentice A; Darboe MK; Prentice AM; Moore SE
Bone; 2016 Feb; 83():1-8. PubMed ID: 26453792
[TBL] [Abstract][Full Text] [Related]
12. Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial.
Braithwaite VS; Mwangi MN; Jones KS; Demir AY; Prentice A; Prentice AM; Andang'o PEA; Verhoef H
Am J Clin Nutr; 2021 May; 113(5):1104-1114. PubMed ID: 33675347
[TBL] [Abstract][Full Text] [Related]
13. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
Imel EA; Hui SL; Econs MJ
J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of Fgf23 in Dmp1-null mice.
Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
[TBL] [Abstract][Full Text] [Related]
15. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
Bharati J; Bhatia D; Khandelwal P; Gupta N; Sinha A; Khadgawat R; Hari P; Bagga A
Indian J Pediatr; 2019 Jun; 86(6):555-557. PubMed ID: 30835073
[TBL] [Abstract][Full Text] [Related]
16. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study.
Bagińska J; Liszewska A; Korzeniecka-Kozerska A
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1259-1264. PubMed ID: 31465293
[TBL] [Abstract][Full Text] [Related]
18. Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study.
Munns CF; Simm PJ; Rodda CP; Garnett SP; Zacharin MR; Ward LM; Geddes J; Cherian S; Zurynski Y; Cowell CT;
Med J Aust; 2012 Apr; 196(7):466-8. PubMed ID: 22509879
[TBL] [Abstract][Full Text] [Related]
19. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
